APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 263 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,173,320 | -34.7% | 187,000 | +0.0% | 0.07% | -32.7% |
| Q1 2024 | $10,991,742 | -1.4% | 186,998 | +0.4% | 0.10% | -16.5% |
| Q4 2023 | $11,147,369 | +205.1% | 186,224 | +163.6% | 0.12% | +146.9% |
| Q4 2022 | $3,653,363 | +87.5% | 70,651 | +71.5% | 0.05% | +75.0% |
| Q4 2021 | $1,948,000 | -45.3% | 41,199 | -61.9% | 0.03% | -51.7% |
| Q3 2021 | $3,562,000 | -51.6% | 108,076 | -37.0% | 0.06% | -64.4% |
| Q1 2021 | $7,356,000 | +22.1% | 171,419 | -23.8% | 0.16% | -62.1% |
| Q1 2020 | $6,026,000 | +48.0% | 224,948 | +69.2% | 0.43% | +159.0% |
| Q4 2019 | $4,071,000 | – | 132,947 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,618,300 | $238,527,130 | 33.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,596 | $27,110,996 | 18.37% |
| Avoro Capital Advisors LLC | 11,111,111 | $1,012,222,212 | 13.73% |
| EcoR1 Capital, LLC | 5,451,647 | $496,645,042 | 12.17% |
| Logos Global Management LP | 625,000 | $56,937,500 | 7.74% |
| Finepoint Capital LP | 241,690 | $22,017,959 | 7.62% |
| Cormorant Asset Management, LP | 1,310,000 | $119,341,000 | 6.68% |
| Boxer Capital, LLC | 1,576,000 | $143,574 | 6.66% |
| Saturn V Capital Management LP | 107,406 | $9,784,687 | 5.43% |
| Ghost Tree Capital, LLC | 180,000 | $16,398,000 | 5.41% |